Rochem International Inc Rochem International Inc

X

Digital content for Centessa Pharmaceuticals

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Centessa Pharmaceuticals
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
Cambridge, Massachusetts
Telephone
Telephone
+1.617.468.5770
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.globenewswire.com//news-release/2024/02/09/2826709/0/en/Centessa-Pharmaceuticals-to-Present-Additional-52-Weeks-of-Continuous-Treatment-Data-from-Third-Year-Part-5-of-Ongoing-Phase-2a-Study-of-SerpinPC-for-the-Treatment-of-Hemophilia-at.html

GLOBENEWSWIRE
09 Feb 2024

https://www.globenewswire.com//news-release/2023/12/13/2795497/0/en/Centessa-Pharmaceuticals-to-Present-at-the-42%E2%81%BF%E1%B5%88-Annual-J-P-Morgan-Healthcare-Conference.html

GLOBENEWSWIRE
13 Dec 2023

https://www.globenewswire.com//news-release/2023/12/10/2793464/0/en/Centessa-Pharmaceuticals-Announces-New-Data-from-an-Additional-52-Weeks-of-Continuous-Treatment-from-Third-Year-Part-5-of-Ongoing-Phase-2a-Study-of-SerpinPC-for-the-Treatment-of-He.html

GLOBENEWSWIRE
10 Dec 2023

https://www.globenewswire.com//news-release/2023/11/27/2786530/0/en/Anaptys-Expands-Immune-Cell-Modulator-Pipeline-with-Exclusive-License-to-BDCA2-Modulator-Antibody-Portfolio-from-Centessa-Pharmaceuticals.html

GLOBENEWSWIRE
27 Nov 2023

https://www.globenewswire.com//news-release/2023/11/13/2779453/0/en/Centessa-Pharmaceuticals-Reports-Financial-Results-and-Business-Highlights-for-the-Third-Quarter-of-2023.html

GLOBENEWSWIRE
13 Nov 2023

https://www.globenewswire.com//news-release/2023/11/02/2772450/0/en/Centessa-Pharmaceuticals-to-Present-Additional-52-Weeks-of-Continuous-Treatment-Data-from-Third-Year-of-Ongoing-Phase-2a-Study-of-SerpinPC-for-the-Treatment-of-Hemophilia-at-Americ.html

GLOBENEWSWIRE
02 Nov 2023

https://www.globenewswire.com//news-release/2023/10/31/2770097/0/en/Centessa-Pharmaceuticals-Announces-Dosing-of-First-Subject-in-Registrational-PRESent-3-Study-Evaluating-SerpinPC-for-the-Treatment-of-Hemophilia-B-with-Inhibitors.html

GLOBENEWSWIRE
31 Oct 2023

https://www.globenewswire.com//news-release/2023/10/30/2769157/0/en/Centessa-Pharmaceuticals-to-Participate-in-Upcoming-Investor-Conferences.html

GLOBENEWSWIRE
30 Oct 2023

https://www.globenewswire.com//news-release/2023/10/25/2766435/0/en/Centessa-Pharmaceuticals-Announces-Preclinical-Data-Supporting-ORX750-s-Potential-as-a-Best-in-Class-Oral-OX2R-Agonist-for-the-Treatment-of-Narcolepsy-and-Other-Sleep-Wake-Disorder.html

GLOBENEWSWIRE
25 Oct 2023

https://www.globenewswire.com//news-release/2023/10/03/2753571/0/en/Centessa-Pharmaceuticals-Announces-Additions-to-Senior-Leadership-Team.html

GLOBENEWSWIRE
03 Oct 2023
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY